08/27/2025
3:44 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2025
7:22 AM | BioNTech (Subject)
Tureci Ozlem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2025
7:27 AM | BioNTech (Subject)
Medine GmbH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2025
7:43 AM | BioNTech (Filer)
| Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions | |
08/11/2025
5:37 AM | BioNTech (Filed by)
CureVac N.V. (Subject)
| Form 425 | |
08/11/2025
5:24 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2025
6:57 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/04/2025
7:01 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2025
7:53 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2025
7:32 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2025
3:40 PM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for BNTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter. |
06/04/2025
3:47 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144/A | |
06/04/2025
7:31 AM | BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
6:20 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025
8:00 AM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2025
7:58 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2025
5:14 PM | BioNTech (Subject)
Medine GmbH (Filed by)
| Form SCHEDULE 13G/A | |
05/07/2025
6:30 AM | BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
6:33 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025
5:53 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/05/2025
5:33 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2025
6:54 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
5:57 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
6:00 AM | BioNTech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/27/2025
6:57 AM | BioNTech (Subject)
Richardson Ryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
6:53 AM | BioNTech (Subject)
Medine GmbH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
6:50 AM | BioNTech (Subject)
Poetting Sierk (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/03/2025
6:02 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
5:58 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024
6:25 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024
6:21 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024
4:56 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
4:25 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
5:35 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:57 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
4:50 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
5:37 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
4:06 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
6:38 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024
5:49 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
5:53 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Capital Gains Tax Strategies for Seniors (Ad) Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure.
SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation. Click here to see the three strategies and get matched with a financial advisor today. |
11/04/2024
5:57 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2024
8:04 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2024
4:03 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
7:41 AM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:15 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:13 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:24 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
3:17 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
4:14 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
5:18 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
7:12 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
3:52 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
4:12 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
6:14 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
8:17 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
6:28 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
4:35 PM | ATHOS KG (Reporting)
BioNTech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
7:53 AM | BioNTech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
MarketBeat All Access